Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk H-D, Lehmkuhl H, Kern F. Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells. J Exp Med 201: 1031–1036, 2005. [PubMed] [Reprint]

Danke NA, Koelle DM, Kwok WW. Persistence of herpes simplex virus type 2 VP16-specific CD4(+) T cells. Hum Immunol 66: 777-87, 2005. [PubMed] [Reprint]

Game DS, Hernandez-Fuentes MP, Lechler RI. Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro. Am J Transplant 3: 454-64, 2005. [PubMed]

Gebauer BS, Hricik DE, Atallah A, Bryan K, Riley J, Tary-Lehmann M, Greenspan NS, Boehm BO, Hering BJ, Heeger PS. Evolution of the Enzyme-Linked Immunosorbent Spot
Assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplantation 2:857-866, 2002. [Abstract] [$Full Text$]

Giannoni F, Barnett J, Bi K, Samodal R, Lanza P, Marchese P, Billetta R, Vita R, Klein MR, Prakken B, Kwok WW, Sercarz E, Altman A, Albani S. Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane. J Immunol 174: 3204-11, 2005. [PubMed] [Reprint]

Gonzalez JC, Kwok WW, Wald A, McClurkan CL, Huang J, Koelle DM. Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2. J Infect Dis 191: 243-54, 2005. [PubMed] [Reprint]

Hernandez-Fuentes MP, Lechler RI. Chronic graft loss: Immunological and non-immunological factors. In "Kidney Transplantation: Strategies to Prevent Organ Rejection. Ronco C., Chiaramonte S., Remuzzi G (eds). Contrib Nephrol, Basel , Karger, 146: 54-64, 2005. [PubMed]

Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA. Decreased Foxp3 levels in multiple sclerosis patients. J Neurosci Res 81: 45-52, 2005. [PubMed] [Reprint]

Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3:689-96, 2003. [Abstract]

Miao D, Yu L, Tiberti C, Cuthbertson DD, Rewers MJ, DiMario U, Eisenbarth GS, Dotta F. ICA512(IA-2) Epitope Specific Assays Distinguish Transient from Diabetes Associated Autoantibodies. J Autoimmun 2002; 18:191-6. [Abstract] [$Full Text$]

Mallone R, Kochik SA, Reijonen H, Carson B, Ziegler SF, Kwok W, Nepom GT. Functional avidity directs T-cell fate in autoreactive CD4+ T-cells. Blood 102: 4103-8, 2005. [PubMed] [Reprint]

Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M. Messenger RNA for FOXP3 in the urine of renal allograft recipients. New Engl J Med 353: 2342-51, 2005. [PubMed] [Reprint]

Seyfert-Margolis,V., Gisler,T.D., Asare,A.L., Wang,R.S., Dosch,H.M., Brooks-Worrell,B., Eisnenbarth,G.S., Palmer,J.P., Greenbaum,C.J., Gitelman,S.E., Nepom,G.T., Bluestone,J.A., and Herold,K.C. (2006): Analysis of T cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 55: 2588-94, 2006. [PubMed] [Reprint]

Thomson AW, Mazariegos GV, Reyes J, Donnenberg VS, Donnenberg AD, Bentlejewski C, Zahorchak AF, O'Connell PJ, Fung JJ, Jankowska-Gan E, Burlingham WJ, Heeger PS, Zeevi A. Monitoring the patient off immunosuppression: Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 72:S13-22, 2001. [PubMed]

Seyfert-Margolis,V., Gisler,T.D., Asare,A.L., Wang,R.S., Dosch,H.M., Brooks-Worrell,B., Eisnenbarth,G.S., Palmer,J.P., Greenbaum,C.J., Gitelman,S.E., Nepom,G.T., Bluestone,J.A., and Herold,K.C. (2006): Analysis of T cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 55: 2588-94, 2006. [PubMed] [Reprint]

Vandenbark AA. TCR peptide vaccination in multiple sclerosis: boosting a deficient natural regulatory network that may involve TCR-specific CD4+CD25+ Treg cells. Current Drug Targets – Inflammation & Allergy 4: 217-229, 2005. [PubMed]

Mazariegos GV, Zahorchak A, Reyes J, Chapman H, Girnita A, McDade K, Zeevi A, Thompson A. Immunologic Assays in Patients Successfully Withdrawn from Immunosuppression (IS) after Liver Transplantation. [Abstract 521] American Transplant Congress, Boston, MA, May 14-19, 2004. [Abstract]

Mazariegos GV, Zahorchak A, Zeevi A, Flynn B, Logar AJ, Reyes J, Thomson A. Dendritic cell subsets in peripheral blood of patients successfully withdrawn from immunosuppression after liver transplantation (LTx). [Abstract 644] American Transplant Congress, Washington DC, May30 - Jun 4, 2003. [Abstract]

Creticos PS, Lighvani SS, Bieneman AP, Balcer-Whaley SP, Norman PS, Lichtenstein LM, Schroeder JY. Enhanced IL10 Secretion by PBMC During the Ragweed Season: Effects of AIC Immunotherapy vs Placebo. 60th Meeting of the AAAAI, Denver, CO. Mar 3-7, 2003. Abstract 530. [Abstract]

Mazariegos G, Zeevi A, Zahorchuk AF, Ostrowski L, Flynn B, Logar AJ, Dvorchik I, Reyes J, Thomson AW. Myeloid pDC1 is decreased as compared to plasmacytoid pDC2 lineage in peripheral blood of patients successfully withdrawn from immunosuppression after liver transplantation [Abstract 65] XIX Int'l Congress Transplantation, Miami, FL, Aug 25-30, 2002. [Abstract]

Heeger PS, Gebrauer B, Schulak JA, Tary-Lehmann M, Greenspan N, Hricik DE. Post transplant immune monitoring by elispot reveals differences between patients with and without acute rejection. Abstract 1067. American Transplant Congress, Washington DC, Apr 25 - May 1, 2002.

overview | project index | leadership